Skip to main content
Previous Poster Home Next

Physician Preferences on Biomarker Testing in Newly-Diagnosed metastatic NSCLC Patients Who had Insufficient Tumor Tissue
07:30am - 03:45pm EST - April 1, 2023

  • Information
  • Resources
  • Play Recording

Physician Preferences on Biomarker Testing in Newly-Diagnosed metastatic NSCLC Patients Who had Insufficient Tumor Tissue icon

https://jnccn.org/view/journal...


Author(s):
  • Anne Shah, PhD, AstraZeneca Pharmaceuticals, LP

Tags: Outcomes and Health Services Research

Display Label Action
AC23P93 - Physician Preferences on Biomarker Testing in Newly-Diagnosed metastatic NSCLC Patients Who had Insufficient Tumor Tissue Download MP3
093-General Poster Session Download Resource